Gareth Wakefield

Title: Gareth Wakefield: Innovator in Cancer Treatment and UV Screening Technologies

Introduction

Gareth Wakefield is a prominent inventor based in Oxford, GB. He has made significant contributions to the fields of cancer treatment and ultraviolet light screening. With a total of 7 patents to his name, Wakefield's work has the potential to impact medical and environmental applications.

Latest Patents

One of his latest patents focuses on particles for the treatment of cancer in combination with radiotherapy. This invention provides a particle comprising a metal oxide doped with at least one rare earth element. The metal oxide is selected from titanium dioxide, zinc oxide, cerium oxide, and mixtures of two or more thereof. Additionally, the invention includes a pharmaceutical composition comprising these particles, along with their uses in the treatment and diagnosis of cancer. Another notable patent is for ultraviolet light screening compositions. This UV screening composition consists of particles capable of absorbing UV light, which leads to the formation of electrons and positively charged holes within the particles. These particles are designed to minimize the migration of these charges to the surface when exposed to UV light in an aqueous environment.

Career Highlights

Throughout his career, Gareth Wakefield has worked with notable companies such as Isis Innovation Limited and Oxonica Materials Limited. His innovative approaches have garnered attention in both academic and commercial sectors.

Collaborations

Wakefield has collaborated with esteemed colleagues, including Peter James Dobson and John Sebastian Knowland. Their combined expertise has contributed to advancements in their respective fields.

Conclusion

Gareth Wakefield's contributions to cancer treatment and UV screening technologies highlight his role as a leading inventor. His patents reflect a commitment to innovation that could lead to significant advancements in healthcare and environmental protection.